This Viewpoint explores whether ctDNA will have the same far-reaching implications for the future of solid tumor oncology that prostate-specific antigen has had for prostate cancer.
This Viewpoint explores whether ctDNA will have the same far-reaching implications for the future of solid tumor oncology that prostate-specific antigen has had for prostate cancer.